Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Duran

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Emerging Infectious Diseases|January 22, 2020
Actinomycetoma Caused by Actinomadura mexicana, A Neglected Entity in the CaribbeanSimon Bessis, Latifa Noussair, Veronica Rodriguez-Nava, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective studyAurélien Dinh, Clara Duran, Simrandeep Singh, et al.
Journal of Global Antimicrobial Resistance|May 7, 2021
Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature reviewMorgan Matt, Clara Duran, Johan Courjon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Weekly Sequential Antibioprophylaxis for Recurrent Urinary Tract Infections Among Patients With Neurogenic Bladder: A Randomized Controlled TrialAurélien Dinh, Marie-Charlotte Hallouin-Bernard, Benjamin Davido, et al.
Ebiomedicine|July 28, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccinationClara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, et al.
Microorganisms|February 12, 2021
Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort StudyAlexandre Bleibtreu, Laurent Dortet, Remy A Bonnin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2020
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell ResponsesBruna Oriol-Tordera, Alex Olvera, Clara Duran-Castells, et al.
Plos Pathogens|August 8, 2020
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV controlBruna Oriol-Tordera, Maria Berdasco, Anuska Llano, et al.
Jac-Antimicrobial Resistance|October 18, 2024
Effectiveness of temocillin in treatment of non-urinary tract infections caused by ESBL-producing Enterobacterales and risk factors for failureChristel Mamona Kilu, Camille Menvielle, Anne Cataldi, et al.
International Journal of Antimicrobial Agents|August 11, 2019
French national cohort of first use of dalbavancin: A high proportion of off-label useAurélien Dinh, Clara Duran, Patricia Pavese, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Emerging Infectious Diseases|January 22, 2020
Actinomycetoma Caused by Actinomadura mexicana, A Neglected Entity in the CaribbeanSimon Bessis, Latifa Noussair, Veronica Rodriguez-Nava, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective studyAurélien Dinh, Clara Duran, Simrandeep Singh, et al.
Journal of Global Antimicrobial Resistance|May 7, 2021
Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature reviewMorgan Matt, Clara Duran, Johan Courjon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Weekly Sequential Antibioprophylaxis for Recurrent Urinary Tract Infections Among Patients With Neurogenic Bladder: A Randomized Controlled TrialAurélien Dinh, Marie-Charlotte Hallouin-Bernard, Benjamin Davido, et al.
Ebiomedicine|July 28, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccinationClara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, et al.
Microorganisms|February 12, 2021
Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort StudyAlexandre Bleibtreu, Laurent Dortet, Remy A Bonnin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2020
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell ResponsesBruna Oriol-Tordera, Alex Olvera, Clara Duran-Castells, et al.
Plos Pathogens|August 8, 2020
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV controlBruna Oriol-Tordera, Maria Berdasco, Anuska Llano, et al.
Jac-Antimicrobial Resistance|October 18, 2024
Effectiveness of temocillin in treatment of non-urinary tract infections caused by ESBL-producing Enterobacterales and risk factors for failureChristel Mamona Kilu, Camille Menvielle, Anne Cataldi, et al.
International Journal of Antimicrobial Agents|August 11, 2019
French national cohort of first use of dalbavancin: A high proportion of off-label useAurélien Dinh, Clara Duran, Patricia Pavese, et al.
Pageof 11